Engineered virus-mimicking nanovaccine with lymph node–tumor dual-targeting and STING-activating capacity for robust cancer immunotherapy
Zhongjie Wang, Shu‐Jun Liu, Ruiqi Ming, Weiwei Wang, Chenguang Wang, Chuyu Li, Jia-Hua Yang, Fan Zhang, Guihong Lu, Lin Mei, Li-Li Huang
Topics & Concepts
Immunogenic cell deathCancer immunotherapyCytotoxic T cellStingImmunotherapyCancer researchCancer vaccineCD8Lymph nodeImmune systemVirusImmunologyBiologyMedicineAerospace engineeringEngineeringBiochemistryIn vitroExtracellular vesicles in diseaseinterferon and immune responsesImmunotherapy and Immune Responses